Michael Montuori, MD
Pain Medicine · Manchester, NHNPI 1932696069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Boston Scientific at 37.2% of the total. Reporting peaked in 2024 at $1,214 and has fallen 64.3% since, to $434 in 2025. That places this record below the midpoint for pain medicine clinicians in NH, where the typical reported total is $1,993.
Across 25 payments — averaging $79.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$741
- Painteq LLC$338
- Abbott$336
- SPR Therapeutics, Inc$250
- Globus Medical$211
- Bioventus LLC$103
- plus $14 from 1 others
What the payments were for
- Travel & lodging$543%
- Food & beverage$1,93997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $741 |
| Painteq LLC | 4 | $338 |
| Abbott | 2 | $336 |
| SPR Therapeutics, Inc | 3 | $250 |
| Globus Medical | 5 | $211 |
| Bioventus LLC | 1 | $103 |
| Si-bone, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,993 in reported general payments places this provider in the 50th percentile of 38 pain medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 103 | $3,406 |
| Gabapentin | 120 | $1,345 |
| Cyclobenzaprine Hcl | 71 | $592 |
| Duloxetine Hcl | 23 | $492 |
| Tizanidine Hcl | 18 | $131 |
| Methylprednisolone | 17 | $72 |
| Meloxicam | 32 | $43 |
| Tramadol Hcl | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Manchester
- Timothy SieversManchester$1K
- Mohamed El-AnsaryManchester$295
- Praveen SuchdevNashua$72K
- Zubin BatlivalaBedford$18K
- Bert FichmanLebanon$15K
- Dennis ThapaDover$13K
- Michael BovaLebanon$12K
- James MirazitaNashua$10K
- Robert LehnPortsmouth$9K
- Thomas ZoukiDover$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.